Therapy of percutaneous infection around craniofacial implants

Int J Prosthodont. 2009 Nov-Dec;22(6):594-6.

Abstract

This study sought to develop treatment strategies for managing percutaneous infection around craniofacial implants. The present general pathogen situation together with a bacterial resistance were determined in 57 infected peri-implant sites. Forty-four implants were randomly assigned for wound cleaning and split into three groups-two with local antibiotics of proven efficacy and one with 3% hydrogen peroxide (H2O2). The pathogen spectrum differed depending on the severity of the infection, with Staphylococcus aureus clearly correlated with the degree of inflammation (positive correlation: R = 0.72). It was observed that the use of additional local antibiotics was not superior to conventional wound cleaning with 3% H2O2. It is suggested that sulcus fluid flow rate measurements could serve as a simple and reliable objective parameter for recall examinations.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Anti-Infective Agents, Local / therapeutic use*
  • Bacitracin / therapeutic use
  • Drug Combinations
  • Ear
  • Exudates and Transudates
  • Eye, Artificial
  • Face / surgery*
  • Humans
  • Hydrogen Peroxide / therapeutic use
  • Neomycin / therapeutic use
  • Nose
  • Orbital Implants
  • Prosthesis Implantation / instrumentation*
  • Prosthesis-Related Infections / diagnosis
  • Prosthesis-Related Infections / drug therapy*
  • Staphylococcal Infections / diagnosis
  • Staphylococcal Infections / drug therapy*
  • Tetracycline / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Anti-Infective Agents, Local
  • Drug Combinations
  • Bacitracin
  • Hydrogen Peroxide
  • Tetracycline
  • Neomycin